Philip Gribbon und Screeningport - Info zur Person

(1 - 25 von 29

)

Philip Gribbon - eventflo - Andrew Stuartmyeventflo.com

www.myeventflo.com

Philip Gribbon. No Image. Philip Gribbon. CSO. European ScreeningPort GmbH. Germany. Speaker. Colleagues. Ellinger. Dr Bernhard Ellinger. Principal Scientist. Philip Gribbon. No Image. Philip Gribbon. CSO. European ScreeningPort GmbH. Germany. Speaker. Colleagues. Ellinger. Dr Bernhard Ellinger. Principal Scientist.

Wissenschaftler suchen nach neuen Ansätzen für MS- ...Deutsches Ärzteblatt

www.aerzteblatt.de

— ... beschreibt Projektkoordinator Philip Gribbon vom Fraunhofer IME ScreeningPort das längerfristige Ziel. © hil/aerzteblatt.de ...

BMBF fördert Projekt mit 1,2 Mio EuroInformationsdienst Wissenschaft

idw-online.de

— Philip Gribbon vom Fraunhofer IME ScreeningPort das längerfristige Ziel. „Wir möchten mit diesem Vorhaben den Weg von der akademischen Idee bis ...

MitarbeiterTRR 305

www.trr305.de

Philip Gribbon, stellvertretender Abteilungsleiter. Fraunhofer-Institut für Translationale Medizin und Pharmakologie ITMP Forschungsbereich ScreeningPort ... Philip Gribbon, stellvertretender Abteilungsleiter. Fraunhofer-Institut für Translationale Medizin und Pharmakologie ITMP Forschungsbereich ScreeningPort ...

Collaborative Innovation in Drug Discovery: Strategies for ...google.de

books.google.de

Philip Gribbon, PhD, Chief Scientific Officer, European ScreeningPort GMBH, Hamburg, Germany Betty P. Guo, PhD, Office of Research, University of California ...

2. NFDI Konferenz DeBioData Seite 1 von 4DFG - Deutsche Forschungsgemeinschaft

www.dfg.de

Philip Gribbon, Fraunhofer Institute for Molecular Biology and Applied Ecology, ScreeningPort. (.de). Details of the planned ... Philip Gribbon, Fraunhofer Institute for Molecular Biology and Applied Ecology, ScreeningPort. (.de). Details of the planned ...

Strategische MS-Forschungskooperation: UKE und Fraunhofer IME

www.neuromedizin.de

Dr. Philip Gribbon, Fraunhofer IME ScreeningPortHamburg , .de.

Forschungsprojekt zur Wirkstoffentwicklung gegen Multiple ...Hamburg-news.hamburg

www.hamburg-news.hamburg

— sagt Projektkoordinator Dr. Philip Gribbon vom Fraunhofer IME ScreeningPort. sm/kk. Quelle und weitere Informationen.

Confidence in drug discoveryTecan

www.tecan.com

Left to right: Philip Gribbon, Gesa Witt and Markus Wolf with the Fluent system. IME ScreeningPort – part of the Fraunhofer. Institute for Molecular Biology ... Left to right: Philip Gribbon, Gesa Witt and Markus Wolf with the Fluent system. IME ScreeningPort – part of the Fraunhofer. Institute for Molecular Biology ...

Forschungsbereich Drug Discovery - Fraunhofer ITMPFraunhofer ITMP

www.itmp.fraunhofer.de

Discovery Research – ScreeningPort. (Leitung: Dr. Philip Gribbon, Hamburg). Die Expertise der Arbeitsgruppe liegt in der Hochdurchsatzbiologie, etwa bei der ... Discovery Research – ScreeningPort. (Leitung: Dr. Philip Gribbon, Hamburg). Die Expertise der Arbeitsgruppe liegt in der Hochdurchsatzbiologie, etwa bei der ...

Full ScheduleSched

slastranslatingresearchidea2016.sched.com

Philip Gribbon is Assistant Head of Department at Fraunhofer IME ... Philip Gribbon is Assistant Head of Department at Fraunhofer IME ScreeningPort, and ... Philip Gribbon is Assistant Head of Department at Fraunhofer IME ... Philip Gribbon is Assistant Head of Department at Fraunhofer IME ScreeningPort, and ...

Philip GribbonChemBioNet

www.chembionet.info

Philip Gribbon. Fraunhofer IME ScreeningPort. Contribution: Assay development and large scale screening centre; Research interest: Target validation, New Assay ... Philip Gribbon. Fraunhofer IME ScreeningPort. Contribution: Assay development and large scale screening centre; Research interest: Target validation, New Assay ...

PublicationsREMEDi4ALL

remedi4all.org

Drug Repurposing at Fraunhofer ITMP ScreeningPort (2024). Authors: Maria Kuzikov, Jeanette Reinshagen, Johanna Huchting, Andrea Zaliani, Philip Gribbon. Drug Repurposing at Fraunhofer ITMP ScreeningPort (2024). Authors: Maria Kuzikov, Jeanette Reinshagen, Johanna Huchting, Andrea Zaliani, Philip Gribbon.

Research Division Drug DiscoveryFraunhofer ITMP

www.itmp.fraunhofer.de

Discovery Research – ScreeningPort. (Head: Dr. Philip Gribbon, Hamburg). The expertise of the working group lies in high-throughput biology, such as the ... Discovery Research – ScreeningPort. (Head: Dr. Philip Gribbon, Hamburg). The expertise of the working group lies in high-throughput biology, such as the ...

Risk mitigation in academic drug discoveryNational Institutes of Health (NIH) (.gov)

pubmed.ncbi.nlm.nih.gov

von B Ellinger · · Zitiert von: 7 — Authors. Bernhard Ellinger , Philip Gribbon. Affiliation. 1 a Department ScreeningPort , Fraunhofer-Institut für Molekularbiologie und Angewandte Oekologie ... von B Ellinger · · Zitiert von: 7 — Authors. Bernhard Ellinger , Philip Gribbon. Affiliation. 1 a Department ScreeningPort , Fraunhofer-Institut für Molekularbiologie und Angewandte Oekologie ...

More Predictive Results in Cell-Based Assays: Combining Target ...www.labbulletin.com › articles › predictive-results-c...

www.labbulletin.com

· Guest speaker Dr. Philip Gribbon (European ScreeningPort, Hamburg) will discuss the use of the EnSight system in anti-cancer drug discovery, for ...